EOSINOPHILIC GASTROENTERITIS
Clinical trials for EOSINOPHILIC GASTROENTERITIS explained in plain language.
Never miss a new study
Get alerted when new EOSINOPHILIC GASTROENTERITIS trials appear
Sign up with your email to follow new studies for EOSINOPHILIC GASTROENTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for rare stomach disease
Disease control CompletedThis study tested dupilumab, a drug that calms certain immune reactions, in 41 people aged 12-70 with eosinophilic gastritis, a condition where too many immune cells build up in the stomach lining. Participants received either dupilumab or a placebo injection every two weeks for …
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug shows promise for rare stomach disorder in japanese study
Disease control CompletedThis study tested a drug called CC-93538 (Cendakimab) in 48 Japanese adults and adolescents with eosinophilic gastroenteritis, a condition where certain white blood cells build up in the digestive tract causing pain and other symptoms. The trial was randomized and placebo-control…
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Zofran may ease nasty bowel prep for children needing colonoscopy
Symptom relief CompletedThis pilot study tested whether giving ondansetron (Zofran) before drinking bowel-cleansing liquid helps children have a cleaner colon and feel less sick. 41 kids aged 2 to 20 took either ondansetron or a placebo before their colonoscopy. The study measured bowel cleanliness and …
Matched conditions: EOSINOPHILIC GASTROENTERITIS
Phase: PHASE4 • Sponsor: State University of New York - Downstate Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC